Acquisition of the sevoflurane medicinal product for the period 1.1.2024-31.12.2025 + option period 1.1.2026-31.12.2027. The procurement concerns sevoflurane medicinal products authorised in Finland (ATC group N01AB08). The medicinal products offered must have a marketing authorisation in Finland and be marketed in Finland and available on 1.1.2024.
Acquisition of the sevoflurane medicinal product for the period 1.1.2024-31.12.2025 + option period 1.1.2026-31.12.2027. The procurement concerns sevoflurane medicinal products authorised in Finland (ATC group N01AB08). The medicinal products offered must have a marketing authorisation in Finland and be marketed in Finland and available on 1.1.2024.